Standout Papers

ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to f... 2022 2026 2023 2024220
  1. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion (2024)
    Rongxuan Zhu, Xiaotong Lu et al. Cell Metabolism
  2. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα (2022)
    Dong Guo, Yingying Tong et al. Cell Metabolism

Immediate Impact

1 from Science/Nature 52 standout
Sub-graph 1 of 21

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
2 intermediate papers

Works of Shudi Luo being referenced

Base editing of the mutated TERT promoter inhibits liver tumor growth
2023
Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα
2022 Standout

Author Peers

Author Last Decade Papers Cites
Shudi Luo 409 253 45 130 18 623
Davide Vecchiotti 331 203 26 114 27 567
Sisi He 284 322 29 125 31 662
Naser Jafari 410 253 37 78 24 640
Ying‐Hui Ko 423 321 51 63 14 652
Qingqiong Luo 562 239 20 79 20 672
Xuejiao Chen 464 183 20 59 22 642
He Ren 356 273 33 157 19 703
Weiqi Dang 311 195 44 275 15 699
Yu-Chu Su 289 114 50 102 18 584
Riccardo Bazzoni 408 202 21 66 18 604

All Works

Loading papers...

Rankless by CCL
2026